Erythropoiesis-stimulating agents (ESAs)
Title
Date Published
Selective modulation of the erythropoietic and tissue-protective effects of erythropoietin: Time to reach the full therapeutic potential of erythropoietin.
July 10, 2007
Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data.
July 1, 2007
Darbepoetin alfa for treatment of anaemia in a case of chronic renal failure during pregnancy–case report.
June 30, 2007
Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
June 30, 2007
Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
June 30, 2007
Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
June 29, 2007
Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
April 23, 2007
Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
April 1, 2007
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.
March 6, 2007
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
March 1, 2007
Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy.
March 1, 2007
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
February 14, 2007
Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins.
February 3, 2007
Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
January 23, 2007
Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure.
January 11, 2007
EPO in cancer anemia: Benefits and potential risks.
December 29, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
December 1, 2006
Correction of anemia with epoetin alfa in chronic kidney disease.
November 16, 2006
New agents that stimulate erythropoiesis.
October 10, 2006
Blood loss management in high-risk patients undergoing total knee arthroplasty: a comparison of two techniques.
October 1, 2006